Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.5786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Wendy Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Atrial Appendage, Stroke, Atrial Fibrillation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Themen: Schlaganfall
Abstract (Originalsprache)
Purpose
Among patients with atrial fibrillation (AF), a nonpharmacologic option (e.g., percutaneous left atrial appendage occlusion [LAAO]) is needed for patients with oral anticoagulant (OAC) contraindications. Among beneficiaries in the Medicare fee‐for‐service coverage 20% sample databases (2015–18) who had AF and an elevated CHA 2 DS 2 ‐VASc score, we assessed the association between percutaneous LAAO versus OAC use and risk of stroke, hospitalized bleeding, and death.
Methods
Patients undergoing percutaneous LAAO were matched to up to five OAC users by sex, age, date of enrollment, index date, CHA 2 DS 2 ‐VASc score, and HAS‐BLED score. Overall, 17 156 patients with AF (2905 with percutaneous LAAO) were matched (average ± SD 78 ± 6 years, 44% female). Cox proportional hazards model were used.
Results
Median follow‐up was 10.3 months. After multivariable adjustments, no significant difference for risk of stroke or death was noted when patients with percutaneous LAAO were compared with OAC users (HRs [95% CIs]: 1.14 [0.86–1.52], 0.98 [0.86–1.10]). There was a 2.94‐fold (95% CI: 2.50–3.45) increased risk for hospitalized bleeding for percutaneous LAAO compared with OAC use. Among patients 65 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
- Lillehei Heart Institute and Department of Medicine (Cardiovascular Division), University of Minnesota Medical School, Minneapolis, Minnesota, USA.
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Wendy Wang
Förderung
- NHLBI NIH HHS
Zitieren
APA
Wang, W., Chen, L. Y., Walker, R. F., Alonso, A., Norby, F. L., Lakshminarayan, K., & Lutsey, P. L. (2024). Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5786
Vancouver
Wang W, Chen LY, Walker RF, Alonso A, Norby FL, Lakshminarayan K, et al. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5786
BibTeX
@article{Wang2024,
author = {Wang, Wendy and Chen, Lin Yee and Walker, Rob F and Alonso, Alvaro and Norby, Faye L and Lakshminarayan, Kamakshi and Lutsey, Pamela L},
title = {Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.5786}
}
EUVIMED